NCT06667791

Brief Summary

Background: The intra-articular injection is considered the first line of minimally invasive treatment in TMJ-ID patients who do not respond to conservative treatment. Image-guided puncture technique has emerged to add safety, reliability, convenience, and decrease the need for correcting the puncture point. Aim of the study: To evaluate the feasibility and clinical outcomes of computer-guided superior joint space injection of sodium hyaluronate in the treatment of temporomandibular joint disorder (TMJ-ID) compared with conventional injection

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 3, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 21, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 24, 2024

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

October 30, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 31, 2024

Completed
Last Updated

October 31, 2024

Status Verified

October 1, 2024

Enrollment Period

4 months

First QC Date

October 30, 2024

Last Update Submit

October 30, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in TMJ dysfunction

    A modified version of Helkimo's clinical dysfunction index (Di) is be calculated to assess the TMJ dysfunction as follows: * Maximum unassisted mouth opening range: Opening range will be determined by asking the patient to gently open mouth and measure the distance between upper and lower central incisors. * Mandibular deviation during opening: Patients will be asked to open mouth gently and deviation will be noted between maxillary and mandibular midline, score 0 - if \<2 mm, score 1 - if 2-5 mm, and score 5 - if \>5 mm

    Baseline, 1 month, and 3 months

  • change in pain score

    Pain level was determined by the patient's self-assessment using a visual analog scale (VAS) from zero to 10 ("0" is pain-free and "10" is severe intolerable pain).

    Baseline,1 months, and 3 months

Secondary Outcomes (2)

  • Duration of operation

    Baseline

  • Number of Needle Relocation

    Baseline

Study Arms (2)

Study Group

EXPERIMENTAL
Other: Computer guided sodium hyaluronate injections

Control

ACTIVE COMPARATOR
Other: conventional sodiumhyaluronate injections

Interventions

Patients will be treated with Computer guided sodium hyaluronate injections in superior TMJ space

Study Group

Patients will be treated with conventional sodium hyaluronate injections in superior TMJ space

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. Patients diagnosed with internal derangement according to Wilkins stage I and II.
  • Patients who would not respond to conservative treatment as a first line of treatment.

You may not qualify if:

  • Patients with Wilkins stage III, IV, V.
  • History of mandibular fracture.
  • Lactating, pregnant or planning pregnancy women.
  • Known hypersensitivity to hyaluronic acid or clear biocompatible photopolymer resin.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Outpatient clinic of Oral and Maxillofacial Surgery

Alexandria, 00302, Egypt

Location

MeSH Terms

Conditions

Temporomandibular Joint Disorders

Condition Hierarchy (Ancestors)

Craniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Lecturer of Dental Public Health and biostatistical consultant

Study Record Dates

First Submitted

October 30, 2024

First Posted

October 31, 2024

Study Start

May 3, 2024

Primary Completion

August 21, 2024

Study Completion

October 24, 2024

Last Updated

October 31, 2024

Record last verified: 2024-10

Locations